Patient acceptance is a particularly relevant method of assessing currently employed epidural and intravenous techniques of opioid analgesia after elective caesarean section. We have prospectively studied 71 such patients, randomised postoperatively to receive epidural morphine, intravenous morphine or intravenous pethidine. When compared with either intravenous opioid, epidural morphine provided twofold better average or excellent analgesia with 30% less drowsiness but with about 50% more pruritus. In spite of this troublesome complication, more patients (83% vs 74%) preferred epidural to intravenous opioid analgesia.
Analgesia after caesarean section has been studied extensively in attempts to provide adequate pain relief as well as allowing maternal interaction with the newborn. 2 ,3 Many studies have demonstrated the superior analgesic effects of epidural opioids compared with traditional intramuscular administration. 1, 6, 8 Others have examined the effect of different doses of epidural morphine. 4 ,8 In this study we have compared epidural morphine with continuous intravenous morphine and pethidine, with particular emphasis on patient preference for these forms of analgesia. Although consideration was given to inclusion of a group receiving epidural pethidine, this was not feasible in our institution at the time of study, since nursing regulations precluded management of epidural opioid infusions and bolus doses of epidural pethidine would require frequent anaesthetic attendance (two-to four-hourly) which could not be guaranteed.
PATIENTS AND METHODS Patients
All patients undergoing elective caesarean section were eligible for inclusion. The only criteria for exclusion were unwillingness of an individual patient or her anaesthetist to participate, or previous sensitivity of the patient to morphine or pethidine. An explanation was given preoperatively of the pain scale to be used postoperatively by the patient. This scale was a simple visual analogue one with an estimation requested from 1 to 10.
Epidural anaesthesia was performed on all patients using lignocaine 2% with adrenaline 1 :200,000 given by an epidural catheter at the L2-L3 or L3-L4 interspace. A volume (average 20 ml) sufficient to provide anaesthesia to the T8level was used. At the completion of surgery and immediately before transfer to the recovery area, the patients were given one of three forms of analgesia, for which they had been randomised according to their hospital unit record number:-1. An initial epidural injection of morphine sulphate (4 mg in 5 ml of isotonic saline, followed by the same dose as top-up upon patient request after a minimum of six hours), 2. Continuous intravenous morphine (loading dose of 2.5-5 mg over 10 minutes and maintenance dose of 1-3 mg per hour, adjusted by the nursing staff), or 3. Continuous intravenous pethidine (loading dose of 25-50 mg over 10 minutes and maintenance dose of 10-30 mg per hour, adjusted by the nursing staff). After the initial dose, the criteria for further analgesia were common to all three regimens and were based on patient demand. Changes in intravenous opioid infusion regimens were made within written guidelines according to patient demand. Epidural analgesia was also 'topped-up' on patient request by the anaesthetist on call. Naloxone was kept at the bedside both for ~mergency treatment of respiratory depression (in Incremental doses of 0.1 mg to a maximum of 0.4 mg) and as the recommended treatment for severe pruritus (in incremental doses of 0.04 mg to a maximum of 0.12 mg). All patients were nursed in the routine post-natal wards, in specific areas caesarean section (i.e. increased nursing surveillance areas).
Assessment
At appr?ximately 24 hours (range 22-26 hour), the followmg assessments were made by a medical member of the anaesthetic staff or by the anaesthetic research nurse:-1. Details of analgesia, viz duration of analgesia and number of top-ups, for the epidural group, and dose rate and total dose for the intravenous group. 2. Side-effects noted and severity recorded (semiquantitative grades 1, 2 and 3), under the headings of nausea and vomiting, dizziness, drowsiness, paraesthesia, urinary retention (after catheter removal) and pruritus. Respiratory depression was assessed from the nursing observations of respiratory rate (measured 15 minutely for two hours then hourly for 24 hours) and from continuous pulse oximetry in all patients receiving epidural morphine. 3. Patient awareness of the worst, the average and the least pain felt during the preceding 24 hours, as assessed by a score from 1 to 10 at this time using the previously explained pain scale. 4. The overall quality of pain relief as assessed by the patient and expressed semi-quantitatively as excellent, good, fair or poor. Patients were also asked if they would like the same form of analgesia again on a future occasion. 5. Nursing record of quality of pain relief noted eight-hourly semi-quantitatively as excellent, good, fair or poor, together with any technical or other problems related to the analgesic administration.
Ethics
The study was approved by the hospital's Ethics Committee and informed written consent was obtained from all patients. Although a double-blind study design would have been preferred, this was not considered ethical or practical. First, it would have involved placebo intravenous infusions in patients given epidural morphine and placebo epidural injections (original and top-up) in patients given intravenous opioid. Second, it would have been impossible to know how to adjust the combined active and placebo agents in response to clinical need. Finally, the assessment was co~sidered reasonably unbiased, as it was based on an Independent collation of objective findings and patient appraisal rather than on observer judgement.
RESULTS
Of the 71 patients, 25 received epidural morphine (group 1), 23 received continuous intravenous morphine (group 2) and 23 received continuous intravenous pethidine (group 3). There were no statistically significant differences between the three groups with respect to age, weight, ASA status, smoking history and patient compliance. The average dose over 24 hours for intravenous ~orphine was 54 mg (range 33-94 mg) and for mtrav.enous pethid~ne 561 mg (range 295-845 mg); for epIdural morphIne 64% received only the initial dose (4 mg) and the remaining 36% received one top-up (also 4 mg) at an average of 17 hours (range 7-22 hours).
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Average Least FIGURE 2.-Least, average and worst pain as a score from I to 10 averaged for each group. The incidence of side-effects is shown in Figure  1 . No respiratory depression was observed in any group. The least side-effects overall were observed with intravenous pethidine, with the lowest incidence of nausea, vomiting, dizziness, paraesthesia and pruritus. The difference for nausea (26% group 3 v. 70% group 2 and 60% group I) was statistically significant (P = 0.008). The incidence of drowsiness was least with epidural morphine (53% v. 82% group 2 and 82% group 3), a difference that was statistically significant (P= 0.02). The overall incidence of pruritus was much higher with epidural morphine (80% v. 35% group 2 and 26% group 3, P= 0.0003). However, only 28% experienced severe pruritus with epidural morphine and only 12% required intravenous naloxone, a treatment which provided rapid and effective relief. The remaining patients were not disturbed by this symptom and declined treatment.
No. 
No patient in either intravenous group required treatment for pruritus.
The patients' estimates of pain scores are shown in Figure 2 . Results with epidural morphine were superior for all levels of pain estimates by the patient. Pain scores for intravenous morphine and pethidine were identical.
Patient appraisal of the overall quality of pain relief is shown in Figure 3 . Epidural morphine was markedly superior (P= 0.01), with 64% reporting excellent pain relief (v. 22% group 2 and 30% group 3). There was no statistically significant difference in overall pain relief between intravenous morphine and pethidine.
The appraisal of pain relief assessed by the nursing staff is shown in Figure 4 . It showed the same trend as the patients' own appraisal, with epidural morphine again being significantly superior (P= 0.004).
Patient preference for the same form of analgesia is shown in Figure 5 . Most were happy with their analgesia and there was no statistically significant difference between the three groups.
DISCUSSION
Analgesia after caesarean section must provide satisfactory pain relief as well as allow the mother to care for her newborn baby. Traditional intramuscular opioid analgesia may cause both unacceptable side-effects and unsatisfactory analgesia, varying from excessive somnolence to severe pain, depending on the time from the last dose administered. Continuous intravenous opioid analgesia offers more even pain relief, but it may still provide less than optimal levels of pain reliefin some patients because of inadequate nursing adjustment, while also producing similar sideeffects of drowsiness, nausea, vomiting, dizziness and urinary retention.
No. Opioid epidural analgesia has been widely studied since initial reports of this route of administration. 9 When compared with intramuscular morphine administered after caesarean section, it was demonstrated that epidural morphine provided prolonged analgesia, a major decrease in opioid side-effects and negligible other side-effects.I.6,8 A recent study comparing epidural and intramuscular morphine following caesarean section reported better pain relief with epidural morphine but similar side-effects in both patient groups. 12 Urinary retention has been reported with equal frequency from parenteral and epidural opioids. 11
Studies investigating dosage regimens for epidural morphine show that 4-5 mg usually offer optimal analgesia with minimal side-effects. I ,4,8 Despite initial reports of potential respiratory depression after epidural morphine administration,9 doses of 4-5 mg of epidural morphine after caesarean section in large patient populations revealed little (0.4%)10 or no l ,2,6-8 respiratory depression, although higher doses (8 mg) may cause mild respiratory depression. 4 In the present study, no respiratory depression was observed with any of the three analgesic regimens. In a recent review l5 based on cumulative experience with over 10,000 Canadian women, there was no evidence found to suggest that significant respiratory depression occurred after small doses (3-4 mg) of epidural morphine after caesarean section. It was claimed that these patients constitute a 'special case', with potential reasons given as the stimulant effect of high progesterone levels, the lack of risk factors (old age and respiratory disease) and the low doses of morphine used. It was further stated that in all studies to date, 'routine nursing observations have sufficed to document respiratory depression'. Additional respiratory monitoring (pulse oximetry, capnography and measurement of chest impedance) may complement the postoperative routine, but the need for anything above adequate monitoring of respiratory rate in this special group must be questioned.
Most studies report a high incidence of pruritus (50-85%), which is usually mild and easily treated. In this study, 80% of patients in the epidural morphine group reported pruritus. In many of these patients, the symptom was acknowledged only with direct questioning and only in 12% was treatment requested. There were no cases of recurrent oral herpes simplex, a complication which has been reported in some studies in 9-15% of patients receiving epidural morphine. 16 This disturbing complication has occurred only in patients with facial pruritus. Furthermore, it occurred in patients with a history of herpes labialis,17 which may thus be considered a relative contraindication to epidural morphine analgesia. Finally, if pruritus can be prevented by oral naltrexone l4 or butorphenol, or is rapidly and effectively treated with IV naloxone, the incidence of recurrent oral herpes simplex would be expected to be negligible.
The present study showed a close similarity in side-effects between the three different treatment groups. Intravenous pethidine produced the least side-effects, especially nausea, and there was little difference between intravenous and epidural morphine, except for a marked increase in the incidence of pruritus in the latter group. This was usually mild and the few severe instances were easily treated with a small intravenous bolus of naloxone. Although the incidence of drowsiness was significantly least with epidural morphine, it was nevertheless unexpectedly high, occurring in about half the patients. This may have been contributed to by patient factors such as previous sleep deprivation and preoperative anxiety.
The patients reported that the overall level of analgesia was significantly better with epidural morphine, and this was confirmed by the nursing reports. Although the questionnaire did not include an assessment of patient mobility, it was indicated strongly by the nursing staff that patients given epidural morphine were also more alert and more easily able to mobilize and care for their babies. The response to whether the same form of analgesia would be acceptable on a future occasion showed a high level of patient acceptance of all three analgesic regimens, although this finding is limited by the fact that each patient received necessarily only one analgesic regimen and thus a direct comparison could not be made.
Overall, this study showed that intravenous opioids, especially pethidine, provide satisfactory analgesia after caesarean section. Although there is little improvement in the side-effects experienced when epidural morphine is used, the analgesia is significantly better and the need for nursing attention directed to analgesic requirements is greatly reduced. The additional nursing time is available for other patient needs such as mothercrafting, and the frequently troublesome management of intravenous analgesia pumps is avoided. Epidural morphine would probably provide ideal analgesia after caesarean section if the annoying side-effect of pruritus (and also recurrent herpes simplex) could be eliminated. Although some promising results in decreasing pruritus have been reported after the addition of droperidol to the epidural opioid 13 and after the use of oral naltrexone,14 this problem remains so far unresolved.
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